Compare Medtronic PLC (MDT) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs ProShares Ultra Gold ETF — how do they compare? Medtronic PLC trades at $82.56 (market cap $106.61B), while ProShares Ultra Gold ETF trades at $44.78. The key difference: Medtronic PLC pays a 3.46% dividend while ProShares Ultra Gold ETF pays none. Which is the better fit depends on your goals.
| MDT | UGL | |
|---|---|---|
Market Cap | $106.61B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $105.35 | $85.62 |
52-Week Low | $73.75 | $33.59 |
Enterprise Value | $125.36B | — |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
UGL, the ProShares Ultra Gold ETF, trades at $43.39, down 0.41% amid bearish technical signals. The leveraged ETF faces pressure from higher interest rate expectations and a stronger dollar, with gold struggling to hold the $4,000 support level. Recent news highlights mixed sentiment, with Wall Street bearish on near-term gold prospects but long-term structural drivers like central bank buying remaining intact.
Outlook remains cautious as UGL's performance hinges on gold price volatility and Fed policy. Risks include leveraged decay and macroeconomic shifts, while opportunities exist if gold resumes its bull trend. Investors should weigh the ETF's high sensitivity to daily gold moves against current bearish technical and sentiment indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
